PharmEasy, the e-pharmacy startup, has acquired peer Medlife for an undisclosed amount. This agreement skyrockets PharmEasy’s position to India's largest medicine delivery platform.
As part of the deal, Pharmeasy will absorb Medlife's existing customers. In order to set up their new accounts, Medlife's existing users will have to log in on PharmEasy's app using the same mobile number they were using on the older platform. That will pull up all digitized prescriptions and saved addresses dating back to a year on the new platform.
Medlife will be discontinuing operations from May 25, 2021. The company’s existing retail partners will be swiftly onboarded onto PharmEasy's platform.
Dr. Dhaval Shah, Co-Founder of the Mumbai-headquartered startup PharmEasy, said in a post on LinkedIn, "We started with the sole purpose of making affordable healthcare accessible to all in 2015. PharmEasy has now covered every single pin code across the country. With this, we aim to reach even more people pan-India and cater to their healthcare needs."
He added that with the acquisition, the startup will be able to service over two million families every month, making it the largest healthcare delivery platform across the country by a distance.